Vitamin C derivative as well as preparation method and application thereof

By replacing sodium ascorbate with bromide under microwave conditions, a stable vitamin C derivative was prepared, which solved the problem of vitamin C easy to dissolve and oxidize, and achieved its stable and effective whitening effect in cosmetics .

CN118994129AActive Publication Date: 2024-11-22GUANGZHOU RUBY BIOTECHNOLOGY CO LTD
View PDF 3 Cites 0 Cited by

Patent Information

Application Number
CN202411087619.0
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-09
Publication Date
2024-11-22
Estimated Expiration
2044-08-09

AI Technical Summary

Technical Problem

Vitamin C is easily soluble in water, is not easily absorbed by the skin, and is easily oxidized and discolored, reducing its whitening effect and utilization efficiency.

Method used

By replacing sodium ascorbate with bromide and polar organic solvent under microwave conditions, a stable vitamin C derivative was prepared and improved its stability and whitening effect by salting, filtration, drying and purification treatment. .

Benefits of technology

The prepared vitamin C derivative has good stability and whitening effects, overcomes the instability of vitamin C to light heat, high and low temperatures and acidic environments, and significantly improves its safety and whitening effect.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118994129A_ABST
    Figure CN118994129A_ABST
Patent Text Reader

Abstract

The invention belongs to the technical field of organic synthesis, and particularly relates to a vitamin C derivative and a preparation method and application thereof. The preparation method of the vitamin C derivative provided by the invention is simple and easy to implement, and the prepared vitamin C derivative has good stability, biological safety and whitening effect.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of organic synthesis, and specifically relates to a vitamin C derivative and a preparation method and application thereof. Background Art

[0002] Vitamin C is also known as sodium ascorbate. Sodium ascorbate is a naturally occurring antioxidant and free radical scavenger, and is also a recognized whitening agent in cosmetics. However, sodium ascorbate is easily soluble in water, not easily absorbed by the skin, and easily oxidized to cause discoloration, thereby reducing its utilization efficiency and its application in daily chemicals. Therefore, providing a stable, safe, and whitening vitamin C derivative is a technical problem that needs to be solved urgently by those skilled in the art. Summary of the invention

[0003] The purpose of the present invention is to provide a vitamin C derivative and a preparation method and application thereof. The vitamin C derivative provided by the present invention is not only stable and safe, but also has a good whitening effect.

[0004] In order to achieve the above object, the present invention provides the following technical solutions:

[0005] The present invention provides a vitamin C derivative having a structure shown in Formula I:

[0006]

[0007] The present invention also provides a method for preparing the vitamin C derivative described in the above technical solution, comprising the following steps:

[0008] Mixing sodium ascorbate, bromide and a polar organic solvent, and performing a substitution reaction to obtain the vitamin C derivative;

[0009] The bromide has a structure shown in Formula II:

[0010]

[0011] Preferably, the molar ratio of sodium ascorbate to bromide is 1:1 to 10:1.

[0012] Preferably, the polar organic solvent includes one or more of DMSO, DMF and 1,4-dioxane.

[0013] Preferably, the substitution reaction is carried out under microwave conditions; the temperature of the substitution reaction is 60-140° C., and the time is 10-50 min.

[0014] Preferably, after the substitution reaction is completed, the obtained reaction system is further subjected to salting out; the salting out process is: pouring the reaction system into saturated saline solution under stirring.

[0015] Preferably, after the salting out, the obtained system is filtered, dried and purified in sequence.

[0016] Preferably, the purification comprises dissolving, filtering and concentrating in sequence; the solvent used for the dissolution comprises one or more of methanol, ethanol, isopropanol and deionized water.

[0017] The present invention also provides the use of the vitamin C derivative described in the above technical solution or the vitamin C derivative prepared by the preparation method described in the above technical solution in cosmetics.

[0018] The present invention provides a vitamin C derivative having a structure shown in Formula I:

[0019]

[0020] The vitamin C derivative provided by the present invention has good stability, biological safety and whitening effect. The results of the embodiment show that the m / z of the vitamin C derivative prepared by the present invention is: 633.2670 [M+Na] + The vitamin C derivative prepared by the present invention greatly overcomes the disadvantages of vitamin C's instability to light, heat, high and low temperatures and acidic environments. BRIEF DESCRIPTION OF THE DRAWINGS

[0021] Figure 1 This is a mass spectrometry characterization diagram of the vitamin C derivative prepared in Example 1;

[0022] Figure 2 This is the ultraviolet absorption spectrum of the vitamin C derivative prepared in Example 1;

[0023] Figure 3 This is the UV absorption spectrum of the stability test of ordinary vitamin C;

[0024] Figure 4 This is a diagram showing the whitening effect of the vitamin C derivative prepared in Example 1 on zebrafish;

[0025] Figure 5 This is a bar graph showing the inhibition of melanin production by the vitamin C derivatives prepared in Example 1 at the zebrafish level;

[0026] Figure 6 This is a bar graph showing the inhibition of tyrosinase activity by the vitamin C derivatives prepared in Example 1 at the zebrafish level. DETAILED DESCRIPTION

[0027] The present invention provides a vitamin C derivative having a structure shown in Formula I:

[0028]

[0029] The present invention also provides a method for preparing the vitamin C derivative described in the above technical solution, comprising the following steps:

[0030] Mixing sodium ascorbate, bromide and a polar organic solvent, and performing a substitution reaction to obtain the vitamin C derivative;

[0031] The bromide has a structure shown in Formula II:

[0032]

[0033] In the present invention, unless otherwise specified, all preparation raw materials are commercially available products well known to those skilled in the art.

[0034] In the present invention, the molar ratio of sodium ascorbate to bromide is preferably 1:1 to 10:1, and more preferably 1.5:1.

[0035] In the present invention, the polar organic solvent preferably includes one or more of DMSO, DMF and 1,4-dioxane, and more preferably DMSO. In the present invention, the amount ratio of the polar organic solvent to sodium ascorbate is preferably 15mL:1-1.5mol, and more preferably 15mL:1.5mol. The present invention has no special requirements for the mixing method, and the method familiar to those skilled in the art can be used.

[0036] In the present invention, the substitution reaction is preferably carried out under microwave conditions; the temperature of the substitution reaction is preferably 60 to 140° C., more preferably 80 to 120° C., and more preferably 90° C. In the present invention, the time of the substitution reaction is preferably 10 to 50 min, more preferably 20 to 40 min, and more preferably 30 min.

[0037] After the substitution reaction is completed, the present invention also preferably includes salting out the obtained reaction system; the salting out process is preferably: pouring the reaction system into saturated salt water under stirring. The present invention has no special limitation on the stirring process, and it can be adopted by those skilled in the art; after the stirring is completed, the present invention also preferably includes leaving the reaction system to stand overnight.

[0038] After the salting out, the present invention also preferably includes filtering, drying and purifying the obtained reaction system in sequence. In the present invention, the filtering method is preferably suction filtration. The present invention has no special limitation on the suction filtration process, and it can be adopted by those skilled in the art. In the present invention, the drying method is preferably drying; the drying temperature is preferably 55°C. The present invention has no special limitation on the drying process, and it can be adopted by those skilled in the art.

[0039] In the present invention, the purification preferably includes dissolving, filtering and concentrating in sequence; the solvent used for the dissolution preferably includes one or more of methanol, ethanol, isopropanol and deionized water, and more preferably ethanol. In the present invention, the filtration method is preferably suction filtration, and the present invention has no special limitation on the suction filtration process, and can be used by those skilled in the art. In the present invention, the concentration method is preferably vacuum distillation, and the present invention has no special limitation on the vacuum distillation process, and can be used by those skilled in the art.

[0040] The present invention also provides the use of the vitamin C derivative described in the above technical solution or the vitamin C derivative prepared by the preparation method described in the above technical solution in cosmetics.

[0041] In order to further illustrate the present invention, the vitamin C derivatives provided by the present invention and their preparation methods and applications are described in detail below in conjunction with the accompanying drawings and examples, but they should not be construed as limiting the scope of protection of the present invention.

[0042] Example 1

[0043] 1.5 mol of sodium ascorbate, 1 mol of bromide (as shown in Formula II) and 15 mL of DMSO were added into a reaction container, stirred and mixed evenly, and then heated under microwave radiation at 90° C. for 30 min.

[0044]

[0045] After the reaction, the reaction solution was poured into 100 mL of saturated brine under stirring, stirred evenly, and allowed to stand overnight. The obtained salting-out solution was filtered, and the solid was collected and dried at 55° C. to obtain a crude product.

[0046] The crude product was dissolved with ethanol, the insoluble matter was discarded, the filtrate was distilled under reduced pressure, concentrated and dried to obtain the vitamin C derivative with a yield of 96.5%.

[0047] Example 2

[0048] 1 mol of sodium ascorbate, 1 mol of bromide (as shown in Formula II) and 15 mL of DMSO were added into a reaction container, stirred and mixed evenly, and then heated under microwave radiation at 90° C. for 30 min.

[0049] After the reaction, the treatment method was the same as in Example 1, and the yield was 45.5%.

[0050] Example 3

[0051] 1.5 mol of sodium ascorbate, 1 mol of bromide (as shown in Formula II) and 15 mL of DMSO were added into a reaction container, stirred and mixed evenly, and then heated by microwave radiation at 90° C. for 20 min.

[0052] After the reaction, the treatment method was the same as in Example 1, and the yield was 83.6%.

[0053] Example 4

[0054] 1.5 mol of sodium ascorbate, 1 mol of bromide (as shown in Formula II) and 15 mL of DMSO were added into a reaction container, stirred and mixed evenly, and then heated by microwave radiation at 60° C. for 30 min.

[0055] After the reaction, the treatment method was the same as in Example 1, and the yield was 63.2%.

[0056] Performance Testing

[0057] 1. Mass spectrometry was performed on the vitamin C derivative prepared in Example 1. The results are as follows: Figure 1 As shown. Figure 1 It can be seen that the m / z of the vitamin C derivative prepared in Example 1 is: 633.2670 [M+Na] + .

[0058] 2. The vitamin C derivative prepared in Example 1 was tested for stability under illumination, different temperatures and different pH values. The testing method was as follows:

[0059] The vitamin C derivative prepared in Example 1 was weighed, prepared into a 1 mg / mL solution using ethanol, and divided into 7 portions of equal volume for later use.

[0060] Similarly, weigh vitamin C and prepare a 1 mg / mL solution with water as a control.

[0061] (1) Lighting

[0062] Take a portion of the vitamin C derivative solution and a portion of the vitamin C solution, place them under sunlight for 2 hours respectively.

[0063] (2) Temperature

[0064] Take a portion of the vitamin C derivative solution and a portion of the vitamin C solution, place them at 4°C and 60°C respectively, and keep them at constant temperature for 2 hours.

[0065] (3) pH value

[0066] Take a portion of the vitamin C derivative solution and a portion of the vitamin C solution, and add 1 mol / L hydrochloric acid, distilled water and 1 mol / L sodium hydroxide respectively.

[0067] After two hours, the UV absorption spectrum was measured using a UV spectrophotometer. Figures 2-3 , as shown in Table 1.

[0068] Table 1 Results of stability tests on vitamin C derivatives and vitamin C

[0069] Vitamin C derivatives Vitamin C Maximum absorption wavelength 249nm 265nm No treatment 1.886 1.338 illumination 1.930 1.263 4℃ 1.970 1.305 60℃ 1.870 1.193 hydrochloric acid 1.775 0.799(245nm) Distilled water 1.594 1.038 Sodium hydroxide 1.530(263nm) 0.247

[0070] From Table 1 and Figures 2-3 From the results, we can see that under the conditions of light and high and low temperatures, the absorbance value of the vitamin C derivative does not change much. Since the derivative is soluble in ethanol, a small amount of ethanol may evaporate during the experiment, causing the concentration to increase and the absorbance value to increase accordingly. However, from the overall results, the derivative does not change much under these conditions, proving that the derivative has good stability under light and high and low temperatures.

[0071] In addition, after adding solutions of different pH values, the concentration decreases, and the absorbance value also decreases accordingly. It can be concluded that under acidic conditions, the derivative is relatively stable. Since the derivative is insoluble in water, after adding distilled water, the sample precipitates in water and the content decreases. Under alkaline conditions, the sample precipitates more and the maximum absorption wavelength red-shifts. It can be seen that the derivative is unstable under alkaline conditions and has low solubility in water, but the stability remains unchanged. Under the same conditions, vitamin C is relatively stable under low temperature conditions, and is unstable under light, high temperature, and acid-base conditions. It can be seen that the vitamin C derivative provided by the present invention greatly overcomes the disadvantages of vitamin C's instability to light, heat, and acidic environments.

[0072] 3. The vitamin C derivative prepared in Example 1 was tested for safety, and the testing method was as follows:

[0073] The vitamin C derivative prepared in Example 1 was prepared into a 10 mmol / L mother solution using DMSO for later use.

[0074] The sample was diluted to multiple concentrations (100, 75, 50, 25, 12.5, 6.25, 3.125 μmol / L) with standard dilution water, and 10 fry (24-well cell culture plate, 1.0 mL sample solution) were tested for each concentration. The survival of fry at 24 hpf, 48 hpf and 72 hpf was observed and recorded under a stereo microscope (objective lens 2-3 times), and the cumulative mortality and deformity rate were calculated. The approximate concentration range of the sample dilution corresponding to the cumulative mortality and deformity rate of fry of 0% to 100% was estimated.

[0075] The test results show that the maximum safe concentration of vitamin C derivatives is 75μmol / L, and under the same conditions, the maximum safe concentration of vitamin C is 12.5μmol / L. In comparison, the safety of vitamin C derivatives is greatly improved.

[0076] 4. The vitamin C derivative prepared in Example 1 was tested for its inhibition of melanin production. The test method was as follows:

[0077] After selecting fertilized eggs, 9 hpf healthy AB zebrafish embryos were randomly placed in a 6-well cell culture plate, 30 per well, and 5 mL of solution (12.5 μmol / L) was added to each well. Three replicate wells were set up in each group and incubated in a curve-controlled biochemical incubator.

[0078] After incubation for 72 hours, add the lysate solution and prepare it into a homogenate by ultrasound. Centrifuge, take the precipitate, and shake to fully dissolve the melanin in the centrifuge tube. Take 100 μL of the solution and place it in a 96-well plate. Use an enzyme reader to measure the absorbance at a wavelength of 405 nm. Calculate the inhibition rate of the sample on melanin synthesis according to the following formula:

[0079]

[0080] The experimental data were expressed as mean ± SEM.

[0081] The test results are as follows Figure 5 As shown by Figure 5 It can be seen that after zebrafish were treated with 0.125mM vitamin C derivatives to 72hpf, the melanin production inhibition rate was 9.77±0.75%, an increase of 9.77% compared with the blank control group; after zebrafish were treated with 0.125mM VC to 72hpf, the melanin production inhibition rate was 14.55±0.12%, an increase of 14.55% compared with the blank control group, indicating that the modified vitamin C derivatives and VC both have the effect of inhibiting melanin production.

[0082] 5. The vitamin C derivative prepared in Example 1 was tested for inhibition of tyrosinase activity, and the test method was as follows:

[0083] After selecting fertilized eggs, 9 hpf healthy AB zebrafish embryos were randomly placed in a 6-well cell culture plate, 30 per well, and 5 mL of solution (75, 50, 12.5 μmol / L) was added to each well. Three replicate wells were set up in each group and incubated in a curve-controlled biochemical incubator.

[0084] When the incubation reaches 72 hours, the lysate solution is added and ultrasonically prepared into a homogenate. Centrifuge, take the supernatant and place it in a 96-well plate, add L-DOPA solution at the same time, and incubate for 1 hour. Use an ELISA instrument to detect the absorbance value (OD475nm value) of each experimental group. The tyrosinase activity inhibition rate is calculated according to the following formula:

[0085]

[0086] The experimental data were expressed as mean ± SEM.

[0087] The test results are as follows Figure 6 As shown by Figure 6 It can be seen that after zebrafish were treated with 0.125mM vitamin C derivatives to 72hpf, the tyrosinase activity inhibition rate was 14.14±2.51%, which was 14.14% higher than that of the blank control group; after zebrafish were treated with 0.125mM VC (control) to 72hpf, the tyrosinase activity inhibition rate was 17.41±1.95%, which was 17.41% higher than that of the blank control group, indicating that the modified vitamin C derivatives and VC have a very significant effect in inhibiting tyrosinase activity.

[0088] In summary, after the common vitamin C structure is modified and transformed by the present invention, although the whitening activity of the vitamin C derivative obtained is not significantly improved compared with the parent vitamin C, it still maintains the whitening activity, and compared with the parent structure vitamin C, its stability and safety are greatly improved. It is expected to be used as a safe and stable whitening raw material in cosmetic raw materials, and it also plays a certain guiding role in the modification of the vitamin C structure.

[0089] Although the above embodiment describes the present invention in detail, it is only a part of the embodiments of the present invention, not all of the embodiments. Other embodiments can be obtained based on this embodiment without creativity, and these embodiments all fall within the protection scope of the present invention.

Claims

1. A vitamin C derivative, characterized in that: It has the structure shown in formula I:

2. The method for preparing the vitamin C derivative according to claim 1, characterized in that: The following steps are involved: Mixing sodium ascorbate, bromide and a polar organic solvent, and performing a substitution reaction to obtain the vitamin C derivative; The bromide has a structure shown in Formula II:

3. The preparation method according to claim 2, characterized in that: The molar ratio of the sodium ascorbate to the bromide is 1:1 to 10:

1.

4. The preparation method according to claim 2, characterized in that: The polar organic solvent includes one or more of DMSO, DMF and 1,4-dioxane.

5. The preparation method according to claim 2, characterized in that: The substitution reaction is carried out under microwave conditions; the temperature of the substitution reaction is 60-140° C., and the time is 10-50 minutes.

6. The preparation method according to claim 2 or 5, characterized in that: After the substitution reaction is completed, the obtained reaction system is subjected to salting out. The salting out process is as follows: pouring the reaction system into saturated saline solution under stirring.

7. The preparation method according to claim 6, characterized in that: After the salting out, the obtained reaction system is filtered, dried and purified in sequence.

8. The preparation method according to claim 7, characterized in that: The purification includes dissolving, filtering and concentrating in sequence; the solvent used for the dissolution includes one or more of methanol, ethanol, isopropanol and deionized water.

9. Use of the vitamin C derivative according to claim 1 or the vitamin C derivative prepared by the preparation method according to any one of claims 2 to 8 in cosmetics.

Citation Information

Patent Citations

  • Alkane chain modified formononetin as well as preparation method and application thereof

    CN116217534A

  • Diastereoisomer of vitamin C derivative as well as preparation and application of diastereoisomer

    CN117658963A

  • Flavone derivative, preparation method therefor, application thereof, and skin whitening product comprising same

    WO2021008170A1